This part of ISO 10993 specifies test methods for the assessment of the local effects after implantation of biomaterials intended for use in medical devices.<\/p>\n
This part of ISO 10993 applies to materials that are<\/p>\n
solid and non-absorbable,<\/p>\n<\/li>\n
non-solid, such as porous materials, liquids, gels, pastes, and particulates, and<\/p>\n<\/li>\n
degradable and\/or absorbable, which may be solid or non-solid.<\/p>\n<\/li>\n<\/ul>\n
The test sample is implanted into a site and animal species appropriate for the evaluation of the biological safety of the material. These implantation tests are not intended to evaluate or determine the performance of the test sample in terms of mechanical or functional loading. This part of ISO 10993 can also be applied to medical devices that are intended to be used topically in clinical indications where the surface or lining might have been breached, in order to evaluate local tissue responses.<\/p>\n
The local effects are evaluated by a comparison of the tissue response caused by a test sample to that caused by control materials used in medical devices whose clinical acceptability and biocompatibility characteristics have been established. The objective of the test methods is to characterize the history and evolution of the tissue response after implantation of a medical device\/biomaterial including final integration or absorption\/degradation of the material. In particular for degradable\/absorbable materials, the degradation characteristics of the material and the resulting tissue response should be determined.<\/p>\n
This part of ISO 10993 does not deal with systemic toxicity, carcinogenicity, teratogenicity or mutagenicity. However, the long-term implantation studies intended for evaluation of local biological effects might provide insight into some of these properties. Systemic toxicity studies conducted by implantation might satisfy the requirements of this part of ISO 10993. When conducting combined studies for evaluating local effects and systemic effects, the requirements of both standards is to be fulfilled.<\/p>\n
| PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
|---|---|---|---|---|---|---|---|
| 4<\/td>\n | Contents Page <\/td>\n<\/tr>\n | ||||||
| 5<\/td>\n | European foreword Endorsement notice <\/td>\n<\/tr>\n | ||||||
| 6<\/td>\n | Table 1 \u2014 Correlations between undated normative references and dated EN and ISO standards <\/td>\n<\/tr>\n | ||||||
| 7<\/td>\n | Annex ZA (informative) Relationship between this European Standard and the essential requirements of Directive 93\/42\/EEC [OJ L 169] aimed to be covered <\/td>\n<\/tr>\n | ||||||
| 8<\/td>\n | Table ZA.1 \u2014 Correspondence between this European Standard and Annex I of Directive 93\/42\/EEC [OJ L 169] <\/td>\n<\/tr>\n | ||||||
| 9<\/td>\n | Annex ZB (informative) Relationship between this European Standard and the essential requirements of Directive 90\/385\/EEC [OJ L 189] aimed to be covered <\/td>\n<\/tr>\n | ||||||
| 10<\/td>\n | Table ZB.1 \u2014 Correspondence between this European Standard and Annex I of Directive 90\/385\/EEC [OJ L 189] <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Biological evaluation of medical devices – Tests for local effects after implantation<\/b><\/p>\n |